ArticleJournal of clinical laboratory analysis2019

FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti-FLT3 interaction and flow cytometric method.

Chadarat Ampasavate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.